5 completed, 1 active not recruiting, 1 suspended. 3 Not applicable, 2 Phase 4, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 2, Active not recruiting 1 |
| Phase 4 | 2 | Completed 2 |
| Phase 3 | 1 | Suspended 1 |
Follow deCODE genetics: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Iceland Screens, Treats or Prevents Multiple Myeloma Clinical follow-up 1, Mental Health and Quality of Life questionnaire, Standard follow-up or treatment. - Monoclonal Gammopathy of Undetermined Significance | Not applicable | Active not recruiting | University of Iceland | 80761 | 2016-09-01 | 2025-09-30 |
| Placebo Controlled Study to Generate Data Characterising Safety Parameters and Immune Responses Boostrix, Placebo (Saline) - Prevention of Infections With Bordetella Pertussis | Phase 4 | Completed | University Hospital, Ghent | 240 | 2015-08-24 | 2022-12-20 |
| Biomarkers of Neuropathic Pain in Women Treated for Breast Cancer Cold water test, Autonomic nervous system monitoring, QST - Neuropathic Pain, Breast Cancer | Not applicable | Completed | Helsinki University Central Hospital | 402 | 2014-10-28 | 2024-07-03 |
| Placebo Controlled Study to Generate Data Characterising Clinical Events, Physiological Responses and Immune Responses Fluad, Saline - Safety Markers of Adjuvanted Influenza Vaccine | Phase 4 | Completed | University Hospital, Ghent | 240 | 2014-10-02 | 2022-12-20 |
| Analysis of Markers in the Blood Correlated With Neuropathic Pain Neuropathy | Completed | Christoph Stein, MD | 50 | 2014-07-01 | 2019-02-06 | |
| Effect of Type 2 Diabetes Genetic Risk Information on Health Behaviors and Outcomes Standardized Risk Assessment - Diabetes Mellitus, Type 2 | Not applicable | Completed | Duke University | 450 | 2009-04-01 | 2014-04-10 |
| Veliflapon (DG-031)to Prevent Heart Attacks or Stroke in Patients With a History of Heart Attack or Unstable Angina veliflapon (DG-031) - Acute Coronary Syndrome | Phase 3 | Suspended | deCODE genetics | 3450 | 2006-05-01 | 2006-11-29 |
Breast Neoplasms (2) · Neuralgia (2) · Acute Coronary Syndrome (1) · Angina, Unstable (1) · Behavior (1) · Coronary Artery Disease (1) · Coronary Thrombosis (1) · Diabetes Mellitus (1) · Diabetes Mellitus, Type 2 (1) · Monoclonal Gammopathy of Undetermined Significance (1) · Myocardial Infarction (1)
Sodium Chloride (2) · 2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid (1) · Boostrix (1) · Mental Health (1) · Therapeutics (1) · fluad vaccine (1)
Belgium (2) · United States (2) · Finland (1) · Germany (1) · Iceland (1)
Alex Cho, MD (1) · Christoph Stein, Prof. (1) · Christopher Granger, M.D. (1) · Douglas W Weaver, M.D. (1) · Eija Kalso, MD, PhD (1) · Geert Leroux-Roels, Prof,MD (1) · Geert Leroux-Roels, Prof., MD (1) · Geoffrey Ginsburg, Md, PhD (1) · Gloria Trujillo, MD (1) · Isaac Lipkus, PhD (1) · Julianne O'Daniel, PhD (1) · Scott Joy, MD (1) · Sigurdur Y Kristinsson, Professor (1) · Susanne Haga, PhD (1)
PMID 22257365, PMID 22302620, PMID 27490698, PMID 33725747, PMID 34087967, PMID 35139264, PMID 36747117, PMID 37439374, PMID 38560901, PMID 42447419